Academisch Medisch Centrum Universiteit van Amsterdam

Who is Who in Research

Who is Who in AMC Research

All publications of Prof. dr. P.P. Tak


back

2010

  • Abreu JRF, Dontje W, Krausz S, de Launay D, van Hennik PB, van Stalborch AM, ten Klooster JP, Sanders ME, Reedquist KA, Hordijk PL, Vervoordeldonk MJ, Tak PP. A Rac1 inhibitory peptide suppresses antibody production and paw swelling in the murine collagen-induced arthritis model of rheumatoid arthritis. ARTHRITIS RES THER 2010;12(1):R2.   [ PubMed ]
  • Abreu JRF, Krausz S, Dontje W, Grabiec AM, Delaunay D, Nolte MA, Tak PP, Reedquist KA. Sustained T cell Rap1 signaling is protective in the collagen-induced arthritis model of rheumatoid arthritis. ARTH RHEUM/AR C RES 2010; [aheadofprint]   [ PubMed ]
  • Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. ANN RHEUM DIS 2010;69(9):1580-1588.   [ PubMed ]
  • Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden L, Dijkmans BAC, Tak PP, Wolbink GJ. Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study. ANN RHEUM DIS 2010;69(5):817-821.
  • Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel SO, Lems WF, Aarden L, Dijkmans BAC, Tak PP, Wolbink GJ. Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-TNF naive patients: a cohort study. ANN RHEUM DIS 2010; [aheadofprint]   [ PubMed ]
  • Bevaart L, Vervoordeldonk MJ, Tak PP. Collagen-induced arthritis in mice. METHODS MOL BIOL 2010;602:181-192.   [ PubMed ]
  • Bevaart L, Vervoordeldonk MJ, Tak PP. Evaluation of therapeutic targets in animal models of arthritis: How does it relate to rheumatoid arthritis?. ARTH RHEUM/AR C RES 2010; [aheadofprint]   [ PubMed ]
  • Bisoendial RJ, Levi M, Tak PP, Stroes ESG. The Prothrombotic State in Rheumatoid Arthritis: An Additive Risk Factor for Adverse Cardiovascular Events. SEMIN THROMB HEMOST 2010;36(4):452-457.   [ PubMed ]
  • Bisoendial RJ, Stroes ESG, Kastelein JJP, Tak PP. Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins. NAT REV RHEUMATOL 2010;6(3):157-164.   [ PubMed ]
  • Bos WH, Wolbink GJ, Boers M, Tijhuis GJ, de Vries N, van der Horst-Bruinsma IE, Tak PP, van de Stadt R, van der Laken CJ, Dijkmans BAC, van Schaardenburg D. Arthritis development in arthralgia patients is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. ANN RHEUM DIS 2010; [aheadofprint]   [ PubMed ]
  • Bos WH, Wolbink GJ, Boers M, Tijhuis GJ, de Vries N, van der Horst-Bruinsma IE, Tak PP, van de Stadt RJ, van der Laken CJ, Dijkmans BAC, van Schaardenburg D. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. ANN RHEUM DIS 2010;69(3):490-494.
  • Cantaert T, van Baarsen LG, Wijbrandts CA, Thurlings RM, van de Sande MG, Bos C, van der Pouw TK, Verweij CL, Tak PP, Baeten DL. Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritis. RHEUMATOLOGY 2010;49(1):156-166.   [ PubMed ]
  • Cohen SB, Keystone E, Genovese MC, Emery P, Peterfy C, Tak PP, Cravets M, Shaw T, Hagerty D. Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate. ANN RHEUM DIS 2010;69(6):1158-1161.   [ PubMed ]
  • Cui J, Saevarsdottir S, Thomson B, Padyukov L, van der Helm-van Mil AHM, Nititham J, Hughes LB, de Vries N, Raychaudhuri S, Alfredsson L, Askling J, Wedrén S, Ding B, Guiducci C, Wolbink GJ, Crusius JBA, van der Horst-Bruinsma IE, Herenius M, Weinblatt ME, Shadick NA, Worthington J, Batliwalla F, Kern M, Morgan AW, Wilson AG, Isaacs JD, Hyrich K, Seldin MF, Moreland LW, Behrens TW, Allaart CF, Criswell LA, Huizinga TWJ, Tak PP, Bridges SL Jr, Toes REM, Barton A, Klareskog L, Gregersen PK, Karlson EW, Plenge RM. PTPRC rheumatoid arthritis risk allele is also associated with response to anti-TNF therapy. ARTH RHEUM/AR C RES 2010; [aheadofprint]   [ PubMed ]
  • de Launay D. Ras family GTPase signaling contributions to inflammation and joint destruction in rheumatoid arthritis. s.l.: s.n.; 2010. (233pp.) (ISBN 9789090251011) (PhD thesis. Supervisor(s): Tak PP; co-supervisor(s): Reedquist KA)   [ UvA Dissertations Online ]
  • Dörner T, Kinnman N, Tak PP. Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers. PHARMACOL THERAPEUT 2010;125(3):464-475.   [ PubMed ]
  • Funovits J, Aletaha D, Bykerk V, Combe B, Dougados M, Emery P, Felson D, Hawker G, Hazes JM, Huizinga T, Kay J, Kvien TK, Smolen JS, Symmons D, Tak PP, Silman A. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological Report Phase I. ANN RHEUM DIS 2010;69(9):1589-1595.   [ PubMed ]
  • Gerlag DM, Hollis S, Layton M, Vencovsky J, Szekanecz Z, Braddock M, Tak PP. Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate. ARTH RHEUM/AR C RES 2010; [aheadofprint]   [ PubMed ]
  • Grabiec AM, Krausz S, de Jager W, Burakowski T, Groot D, Sanders ME, Prakken BJ, Maslinski W, Eldering E, Tak PP, Reedquist KA. Histone Deacetylase Inhibitors Suppress Inflammatory Activation of Rheumatoid Arthritis Patient Synovial Macrophages and Tissue. J IMMUNOL 2010;184(5):2718-2728.   [ PubMed ]
  • Herenius MMJ, Hoving JL, Sluiter JK, Raterman HG, Lems WF, Dijkmans BAC, Tak PP, Nurmohamed MT, Voskuyl AE, Frings-Dresen MHW. Improvement of Work Ability, Quality of Life, and Fatigue in Patients With Rheumatoid Arthritis Treated With Adalimumab. J OCCUP ENVIRON MED 2010;52(6):618-621.   [ PubMed ]
  • Hoek RM, de Launay D, Kop EN, Yilmaz-Elis AS, Lin F, Reedquist KA, Verbeek JS, Medof ME, Tak PP, Hamann J. Deletion of either CD55 or CD97 ameliorates arthritis. ARTH RHEUM/AR C RES 2010; [aheadofprint]   [ PubMed ]
  • Hoek RM, de Launay D, Kop EN, Yilmaz-Elis AS, Lin F, Reedquist KA, Verbeek JS, Medof ME, Tak PP, Hamann J. Deletion of Either CD55 or CD97 Ameliorates Arthritis in Mouse Models. ARTH RHEUM/AR C RES 2010;62(4):1036-1042.
  • Khoury M, Courties G, Fabre S, Bouffi C, Seemayer CA, Vervoordeldonk MJ, Tak PP, Jorgensen C, Apparailly F. Adeno-Associated Virus Type 5-Mediated Intraarticular Administration of Tumor Necrosis Factor Small Interfering RNA Improves Collagen-Induced Arthritis. ARTH RHEUM/AR C RES 2010;62(3):765-770.   [ PubMed ]
  • Klarenbeek PL, Tak PP, van Schaik BDC, Zwinderman AH, Jakobs ME, Zhang Z, van Kampen AHC, van Lier RAW, Baas F, de Vries N. Human T Cell Memory Consists Mainly Of Unexpanded Clones. IMMUNOL LETT 2010; [aheadofprint]   [ PubMed ]
  • Kormelink TG, Tekstra J, Thurlings RM, Boumans MHJ, Vos K, Tak PP, Bijlsma JWJ, Lafeber FPJG, Redegeld FA, van Roon JAG. Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity. ANN RHEUM DIS 2010; [aheadofprint]   [ PubMed ]
  • Lindberg J, Wijbrandts CA, van Baarsen LG, Nader G, Klareskog L, Catrina A, Thurlings R, Vervoordeldonk M, Lundeberg J, Tak PP. The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis. PLOS ONE 2010;5(6):e11310.   [ PubMed ]
  • Lodde BM. Local immunomodulatory gene therapy for Sjögren syndrome. s.l.: s.n.; 2010. (149pp.) (ISBN 9789081480215) (PhD thesis. Supervisor(s): Tak PP; co-supervisor(s): Baum BJ)   [ UvA Dissertations Online ]
  • Martin-Trujillo A, van Rietschoten JGI, Timmer TCG, Milena Rodriguez F, Huizinga TWJ, Tak PP, Marsal S, Ibrahim SM, Dijkmans BAC, van der Pouw Kraan TCTM, Verweij CL. Loss of imprinting of IGF2 characterizes high IGF2mRNA-expressing type of Fibroblast-like Synoviocytes in Rheumatoid Arthritis. ANN RHEUM DIS 2010; [aheadofprint]   [ PubMed ]
  • Martin-Trujillo A, van Rietschoten JGI, Timmer TCG, Rodriguez FM, Huizinga TWJ, Tak PP, Marsal S, Ibrahim SM, Dijkmans BAC, Kraan TCTMVDP, Verweij CL. Loss of imprinting of IGF2 characterises high IGF2 mRNA-expressing type of fibroblast-like synoviocytes in rheumatoid arthritis. ANN RHEUM DIS 2010;69(6):1239-1242.
  • Raterman H, Hoving J, Nurmohamed M, Herenius M, Sluiter J, Lems W, Tak P, Dijkmans B, Twisk J, Frings-Dresen M, Voskuyl A. Work ability: a new outcome measure in rheumatoid arthritis?. SCAND J RHEUMATOL 2010;39(2):127-131.   [ PubMed ]
  • Roescher N, Tak PP, Illei GG. Cytokines in Sjogren's syndrome: potential therapeutic targets. ANN RHEUM DIS 2010;69(6):945-948.   [ PubMed ]
  • Rubbert-Roth A, Tak PP, Zerbini C, Tremblay JL, Carreño L, Armstrong G, Collinson N, Shaw TM. Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR). RHEUMATOLOGY 2010;49(9):1683-1693.   [ PubMed ]
  • Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, Li Y, Kurreeman FAS, Zhernakova A, Hinks A, Guiducci C, Chen R, Alfredsson L, Amos CI, Ardlie KG, Barton A, Bowes J, Brouwer E, Burtt NP, Catanese JJ, Coblyn J, Coenen MJH, Costenbader KH, Criswell LA, Crusius JBA, Cui J, de Bakker PIW, de Jager PL, Ding B, Emery P, Flynn E, Harrison P, Hocking LJ, Huizinga TWJ, Kastner DL, Ke X, Lee AT, Liu X, Martin P, Morgan AW, Padyukov L, Posthumus MD, Radstake TRDJ, Reid DM, Seielstad M, Seldin MF, Shadick NA, Steer S, Tak PP, Thomson W, van der Helm-van Mil AHM, van der Horst-Bruinsma IE, van der Schoot CE, van Riel PLCM, Weinblatt ME, Wilson AG, Wolbink GJ, Wordsworth BP, Wijmenga C, Karlson EW, Toes REM, de Vries N, Begovich AB, Worthington J, Siminovitch KA, Gregersen PK, Klareskog L, Plenge RM. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. NAT GENET 2010;42(6):508-U56.   [ PubMed ]
  • Thurlings RM, Boumans M, Tekstra J, van Roon JA, Vos K, van Westing DM, van Baarsen LG, Bos C, Kirou KA, Gerlag DM, Crow MK, Bijlsma JW, Verweij CL, Tak PP. The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis. ARTH RHEUM/AR C RES 2010; [aheadofprint]   [ PubMed ]
  • Thurlings RM, Teng O, Vos K, Gerlag DM, Aarden L, Stapel SO, van Laar JM, Tak PP, Wolbink GJ. Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis. ANN RHEUM DIS 2010;69(2):409-412.
  • van Baarsen LGM, Wijbrandts CA, Gerlag DM, Rustenburg F, van der Pouw Kraan TCTM, Dijkmans BAC, Tak PP, Verweij CL. Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritis. GENES IMMUN 2010; [aheadofprint]   [ PubMed ]
  • van Baarsen LGM, Wijbrandts CA, Rustenburg F, Cantaert T, van der Pouw Kraan TCTM, Baeten DL, Dijkmans BAC, Tak PP, Verweij CL. Regulation of interferon response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment. ARTHRITIS RES THER 2010;12(1):R11.   [ PubMed ]
  • van Baarsen LGM, Wijbrandts CA, Timmer TCG, Kraan TCTMVDP, Tak PP, Verweij CL. Synovial Tissue Heterogeneity in Rheumatoid Arthritis in Relation to Disease Activity and Biomarkers in Peripheral Blood. ARTH RHEUM/AR C RES 2010;62(6):1602-1607.
  • van Baarsen LGM, Wijbrandts CA, Timmer TCG, van der Pouw Kraan TCTM, Tak PP, Verweij CL. Synovial tissue heterogeneity in rheumatoid arthritis in relationship to disease activity and biomarkers in peripheral blood. ARTH RHEUM/AR C RES 2010; [aheadofprint]   [ PubMed ]
  • van Kuijk AWR. Clinical and synovial tissue studies in psoriatric arthritis. S.l.: s.n.; 2010. (143pp.) (ISBN 9789461080707) (PhD thesis. Supervisor(s): Tak PP, Dijkmans BAC)   [ UvA Dissertations Online ]
  • van Kuijk AWR, de Groot M, Stapel SO, Dijkmans BAC, Wolbink GJ, Tak PP. Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis. ANN RHEUM DIS 2010;69(3):624-U187.   [ PubMed ]
  • van Kuijk AWR, Vergunst CE, Gerlag DM, Bresnihan B, Gomez-Reino JJ, Regine R, Verschueren PC, van de Leij C, Maas M, Kraan MC, Tak PP. CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial. ANN RHEUM DIS 2010; [aheadofprint]   [ PubMed ]
  • van Kuijk AWR, Wijbrandts CA, Vinkenoog M, Zheng TS, Reedquist KA, Tak PP. TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade. ANN RHEUM DIS 2010;69(1):301-304.   [ PubMed ]
  • van Leuven SI, van Wijk DF, Volger OL, de Vries JPPM, van der Loos CM, de Kleijn DVP, Horrevoets AJG, Tak PP, van der Wal AC, de Boer OJ, Pasterkamp G, Hayden MR, Kastelein JJP, Stroes ES. Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis. ATHEROSCLEROSIS 2010;211(1):231-236.   [ PubMed ]
  • van Maanen MA, Stoof SP, Larosa GJ, Vervoordeldonk MJ, Tak PP. Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor alpha 7 subunit gene knockout mice. ANN RHEUM DIS 2010;69(9):1717-1723.
  • van Maanen MA, Stoof SP, Larosa GJ, Vervoordeldonk MJ, Tak PP. Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor {alpha}7 subunit gene knockout mice. ANN RHEUM DIS 2010; [aheadofprint]   [ PubMed ]
  • Vosters JL, Landek-Salgado MA, Yin H, Swaim WD, Kimura H, Tak PP, Caturegli P, Chiorini JA. Reply to the letter to the editor by di carlo, airoldi, and pistoia, commenting on the enigmatic role of IL-12 in the pathogenesis of Sjögren's syndrome. ARTH RHEUM/AR C RES 2010; [aheadofprint]   [ PubMed ]

2009

  • Abreu JRF. Small GTPases: emerging targets in rheumatoid arthritis. s.l.: s.n.; 2009. (198pp.) (PhD thesis. Supervisor(s): Tak PP; co-supervisor(s): Reedquist KA)   [ UvA Dissertations Online ]
  • Abreu JRF, de Launay D, Sanders ME, Grabiec AM, van de Sande MG, Tak PP, Reedquist KA. The Ras guanine nucleotide exchange factor RasGRF1 promotes matrix metalloproteinase-3 production in rheumatoid arthritis synovial tissue. ARTHRITIS RES THER 2009;11(4):R121.   [ PubMed ]
  • Abreu JRF, Grabiec AM, Krausz S, Spijker R, Burakowski T, Maslinski W, Eldering E, Tak PP, Reedquist KA. The Presumed Hyporesponsive Behavior of Rheumatoid Arthritis T Lymphocytes Can Be Attributed to Spontaneous Ex Vivo Apoptosis rather than Defects in T Cell Receptor Signaling. J IMMUNOL 2009;183(1):621-630.   [ PubMed ]
  • Bartelds GM, Wijbrandts CA, Nurmohamed MT, Wolbink GJ, de Vries N, Tak PP, Dijkmans BAC, Crusius JBA, Vand der Horst-Bruinsma IE. Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms. ARTH RHEUM/AR C RES 2009;60(8):2541-2542.   [ PubMed ]
  • Barthel C, Yeremenko N, Jacobs R, Schmidt RE, Bernateck M, Zeidler H, Tak PP, Baeten D, Rihl M. Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis. ARTHRITIS RES THER 2009;11(3):R82.   [ PubMed ]
  • Bisoendial RJ, Stroes ESG, Tak PP. Where the immune response meets the vessel wall. NETH J MED 2009;67(8):328-333.   [ PubMed ]
  • Boumans MJH, Tak PP. Rituximab treatment in rheumatoid arthritis: how does it work?. ARTHRITIS RES THER 2009;11(6):134.   [ PubMed ]
  • Bresnihan B, Pontifex E, Thurlings RM, Vinkenoog M, El-Gabalawy H, Fearon U, Fitzgerald O, Gerlag DM, Rooney T, van de Sande MG, Veale D, Vos K, Tak PP. Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers. J RHEUMATOL 2009;36(8):1800-1802.   [ PubMed ]
  • Brittijn SA, Duivesteijn SJ, Belmamoune M, Bertens LFM, Bitter W, Debruijn JD, Champagne DL, Cuppen E, Flik G, Vandenbroucke-Grauls CM, Janssen RAJ, de Jong IML, de Kloet ER, Kros A, Meijer AH, Metz JR, van der Sar AM, Schaaf MJM, Schulte-Merker S, Spaink HP, Tak PP, Verbeek FJ, Vervoordeldonk MJ, Vonk FJ, Witte F, Yuan H, Richardson MK. Zebrafish development and regeneration: new tools for biomedical research. INT J DEV BIOL 2009;53(5-6):835-850.   [ PubMed ]
  • Canete JD, Celis R, Noordenbos T, Moll C, Gomez-Puerta JA, Pizcueta P, Palacin A, Tak PP, Sanmarti R, Baeten D. Distinct synovial immunopathology in Behcet disease and psoriatic arthritis. ARTHRITIS RES THER 2009;11(1):R17.   [ PubMed ]
  • Cantaert T, Brouard S, Thurlings RM, Pallier A, Salinas GF, Braud C, Klarenbeek PL, de Vries N, Zhang Y, Soulillou JP, Tak PP, Baeten D. Alterations of the Synovial T Cell Repertoire in Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis. ARTH RHEUM/AR C RES 2009;60(7):1944-1956.   [ PubMed ]
  • Cantaert T, de Rycke L, Mavragani CP, Wijbrandts CA, Niewold TB, Niers T, Vandooren B, Veys EM, Richel D, Tak PP, Crow MK, Baeten D. Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade. ANN RHEUM DIS 2009;68(6):1022-1029.   [ PubMed ]
  • Daikeler T, Tyndall A, Vervoordeldonk MJ, Tak PP. Cellular therapy in autoimmune disease and gene therapy in rheumatic disease.. In: Bijlsma JWJ, Burmester GR, Da Silva JAP, Faarvang KL, Hachulla E, Mariette X, editors. Compendium on Rheumatic Diseases. London: BMJ Publishing Group; 2009. p. 747-768.
  • Gerlag DM, Tak PP. How to perform and analyse synovial biopsies. BEST PRACT RES CL RH 2009;23(2):221-232.   [ PubMed ]
  • Groot de J, Zuurmond AM, Tak PP. Biological markers. In: Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS, editors. Kelley's textbook of rheumatology. 8th Edition. Philadelphia: W.B. Saunders Co; 2009. p. 475-489.
  • Hamilton JA, Tak PP. The Dynamics of Macrophage Lineage Populations in Inflammatory and Autoimmune Diseases. ARTH RHEUM/AR C RES 2009;60(5):1210-1221.   [ PubMed ]
  • Hoving JL, Bartelds GM, Sluiter JK, Sadiraj K, Groot I, Lems WF, Dijkmans BAC, Wijbrandts CA, Tak PP, Nurmohamed MT, Voskuyl AE, Frings-Dresen MHW. Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6-month course of TNF inhibitors: prospective intervention study and partial economic evaluation. SCAND J RHEUMATOL 2009;38(4):246-250.   [ PubMed ]
  • Huang QQ, Sobkoviak R, Jockheck-Clark AR, Shi B, Mandelin AM 2nd, Tak PP, Haines GK 3rd, Nicchitta CV, Pope RM. Heat Shock Protein 96 Is Elevated in Rheumatoid Arthritis and Activates Macrophages Primarily via TLR2 Signaling. J IMMUNOL 2009;182(8):4965-4973.   [ PubMed ]
  • Keystone E, Emery P, Peterfy CG, Tak PP, Cohen S, Genovese MC, Dougados M, Burmester GR, Greenwald M, Kvien TK, Williams S, Hagerty D, Cravets MW, Shaw T. Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. ANN RHEUM DIS 2009;68(2):216-221.   [ PubMed ]
  • Klaasen R, Thurlings RM, Wijbrandts CA, van Kuijk AW, Baeten D, Gerlag DM, Tak PP. The Relationship Between Synovial Lymphocyte Aggregates and the Clinical Response to Infliximab in Rheumatoid Arthritis A Prospective Study. ARTH RHEUM/AR C RES 2009;60(11):3217-3224.   [ PubMed ]
  • Kop EN, Matmati M, Pouwels W, Leclercq G, Tak PP, Hamann J. Differential expression of CD97 on human lymphocyte subsets and limited effect of CD97 antibodies on allogeneic T-cell stimulation. IMMUNOL LETT 2009;123(2):160-168.   [ PubMed ]
  • Lebre MC, Tak PP. Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance?. HUM IMMUNOL 2009;70(5):321-324.   [ PubMed ]
  • Maksymowych WP, Fitzgerald O, Wells GA, Gladman DD, Landewé R, Ostergaard M, Taylor WJ, Christensen R, Tak PP, Boers M, Syversen SW, Bathon JM, Ritchlin CJ, Mease PJ, Bykerk VP, Garnero P, Geusens P, El-Gabalawy H, Aletaha D, Inman RD, Kraus VB, Kvien TK, van der Heijde D. Proposal for Levels of Evidence Schema for Validation of a Soluble Biomarker Reflecting Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, and Recommendations for Study Design. J RHEUMATOL 2009;36(8):1792-1799.   [ PubMed ]
  • Maksymowych WP, Landewé R, Tak PP, Ritchlin CJ, Ostergaard M, Mease PJ, El-Gabalawy H, Garnero P, Gladman DD, Fitzgerald O, Aletaha D, Bykerk VP, Bathon JM, Syversen SW, Boers M, Geusens P, Inman RD, Kraus VB, Kvien TK, Taylor WJ, Wells GA, van der Heijde D. Reappraisal of OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: The OMERACT 9 v2 Criteria. J RHEUMATOL 2009;36(8):1785-1791.   [ PubMed ]
  • Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, Guiducci C, Catanese JJ, Xie G, Stahl EA, Chen R, Alfredsson L, Amos CI, Ardlie KG, Barton A, Bowes J, Burtt NP, Chang M, Coblyn J, Costenbader KH, Criswell LA, Crusius JBA, Cui J, de Jager PL, Ding B, Emery P, Flynn E, Harrison P, Hocking LJ, Huizinga TWJ, Kastner DL, Ke X, Kurreeman FAS, Lee AT, Liu X, Li Y, Martin P, Morgan AW, Padyukov L, Reid DM, Seielstad M, Seldin MF, Shadick NA, Steer S, Tak PP, Thomson W, van der Helm-van Mil AHM, van der Horst-Bruinsma IE, Weinblatt ME, Wilson AG, Wolbink GJ, Wordsworth P, Altshuler D, Karlson EW, Toes REM, de Vries N, Begovich AB, Siminovitch KA, Worthington J, Klareskog L, Gregersen PK, Daly MJ, Plenge RM. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. NAT GENET 2009;41(12):1313-U76.   [ PubMed ]
  • Rihl M, Barthel C, Klos A, Schmidt RE, Tak PP, Zeidler H, Kuipers JG. Identification of candidate genes for susceptibility to reactive arthritis. RHEUMATOL INT 2009;29(12):1519-1522.
  • Roescher N, Tak PP, Illei GG. Cytokines in Sjogren's syndrome. ORAL DIS 2009;15(8):519-526.
  • Syversen SW, Landewe R, van der Heijde D, Bathon JM, Boers M, Bykerk VP, Fitzgerald O, Gladman DD, Garnero P, Geusens P, El-Gabalawy H, Inman RD, Kraus V, Kvien TK, Mease PJ, Ostergaard M, Ritchlin CJ, Tak PP, Taylor WJ, Maksymowych WP. Testing of the OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage in Rheumatoid Arthritis: A Systematic Literature Search on 5 Candidate Biomarkers. J RHEUMATOL 2009;36(8):1769-1784.   [ PubMed ]
  • Tak PP, editor. New therapeutic targets in rheumatoid arthritis.. Basel: Birkäuser Verlag AG; 2009. (225pp.) (ISBN 978-3-7643-8237-7) (Progress in Inflammation Research)
  • Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H, de Vries N, Tak PP, Chen S, Shen N. MicroRNA-146a Contributes to Abnormal Activation of the Type I Interferon Pathway in Human Lupus by Targeting the Key Signaling Proteins. ARTH RHEUM/AR C RES 2009;60(4):1065-1075.   [ PubMed ]
  • Tas SW, Vervoordeldonk MJBM, Tak PP. Gene Therapy Targeting Nuclear Factor-kappaB: Towards Clinical Application in Inflammatory Diseases and Cancer. CURR GENE THER 2009;9(3):160-170.   [ PubMed ]
  • Thurlings RM, Gerlag DM, Tak PP, Vos K. Re-treatment of rheumatoid arthritis patients who were initial nonresponders to rituximab: comment on the article by Thurlings et al Reply. ARTH RHEUM/AR C RES 2009;60(6):1867-1868.   [ PubMed ]
  • Thurlings RM, Wijbrandts CA, Bennink RJ, Dohmen SE, Voermans C, Wouters D, Izmailova ES, Gerlag DM, van Eck-Smit BLF, Tak PP. Monocyte Scintigraphy in Rheumatoid Arthritis: The Dynamics of Monocyte Migration in Immune-Mediated Inflammatory Disease. PLOS ONE 2009;4(11):e7865.   [ PubMed ]
  • van den Bemt BJF, Vos K, den Broeder AA, Blom M, Thurlings RM, Bartelds GM, Stapel SO, Barrera P, Tak PP, Nurmohamed MT, Wolbink GJ. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis. ANN RHEUM DIS 2009;68(8):1368-1369.   [ PubMed ]
  • van der Heijden JW, Oerlemans R, Dijkmans BAC, Qi H, van der Laken CJ, Lems WF, Jackman AL, Kraan MC, Tak PP, Ratnam M, Jansen G. Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients. ARTH RHEUM/AR C RES 2009;60(1):12-21.   [ PubMed ]
  • van der Heijden JW, Oerlemans R, Tak PP, Assaraf YG, Kraan MC, Scheffer GL, van der Laken CJ, Lems WF, Scheper RJ, Dijkmans BAC, Jansen G. Involvement of Breast Cancer Resistance Protein Expression on Rheumatoid Arthritis Synovial Tissue Macrophages in Resistance to Methotrexate and Leflunomide. ARTH RHEUM/AR C RES 2009;60(3):669-677.   [ PubMed ]
  • van der Laan WH, Faber WR, de Vries N, Maas M, Tak PP. 'Reumatoïde artritis' bij een Surinaamse man: lepra. NED TIJDSCHR GENEESKD 2009;153:A246.   [ PubMed ]
  • van der Leij C, van de Sande MGH, Lavini C, Tak PP, Maas M. Rheumatoid synovial inflammation: pixel-by-pixel dynamic contrast-enhanced MR imaging time-intensity curve shape analysis--a feasibility study. RADIOLOGY 2009;253(1):234-240.   [ PubMed ]
  • van Kuijk AWR, Gerlag DM, Vos K, Wolbink G, de Groot M, de Rie MA, Zwinderman AH, Dijkmans BAC, Tak PP. A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue. ANN RHEUM DIS 2009;68(8):1303-1309.   [ PubMed ]
  • van Maanen MA. Cholinergic nervous system as therapeutic approach for the treatment of arthritis. s.l.: s.n.; 2009. (151pp.) (ISBN 9789064643736) (PhD thesis. Supervisor(s): Tak PP; co-supervisor(s): Vervoordeldonk MJ)   [ UvA Dissertations Online ]
  • van Maanen MA, Lebre MC, van der Poll T, Larosa GJ, Elbaum D, Vervoordeldonk MJ, Tak PP. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. ARTH RHEUM/AR C RES 2009;60(1):114-122.   [ PubMed ]
  • van Maanen MA, Stoof SP, van der Zanden EP, de Jonge WJ, Janssen RA, Fischer DF, Vandeghinste N, Brys R, Vervoordeldonk MJ, Tak PP. The alpha7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: A possible role for a key neurotransmitter in synovial inflammation. ARTH RHEUM/AR C RES 2009;60(5):1272-1281.   [ PubMed ]
  • van Maanen MA, Vervoordeldonk MJ, Tak PP. The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. NAT REV RHEUMATOL 2009;5(4):229-232.   [ PubMed ]
  • Vandooren B, Cantaert T, van Lierop MJ, Bos E, de Rycke L, Veys EM, de Keyser F, Bresnihan B, Luyten FP, Verdonk PC, Tak PP, Boots AH, Baeten D. Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis. ANN RHEUM DIS 2009;68(6):1044-1050.   [ PubMed ]
  • Vandooren B, Melis L, Veys EM, Tak PP, Baeten D. In Vitro Spontaneous Osteoclastogenesis of Human Peripheral Blood Mononuclear Cells Is Not Crucially Dependent on T Lymphocytes. ARTH RHEUM/AR C RES 2009;60(4):1020-1025.   [ PubMed ]
  • Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, Boumans M, Lutter R, Tak PP, Baeten D. Absence of a Classically Activated Macrophage Cytokine Signature in Peripheral Spondylarthritis, Including Psoriatic Arthritis. ARTH RHEUM/AR C RES 2009;60(4):966-975.   [ PubMed ]
  • Vandooren B, Tak PP, Baeten D. Synovial and mucosal immunopathology in spondyloarthritis. ADV EXP MED BIOL 2009;649:71-84.   [ PubMed ]
  • Vandooren B, Yeremenko N, Noordenbos T, Bras J, Tak PP, Baeten D. Mediators of structural remodeling in peripheral spondylarthritis. ARTH RHEUM/AR C RES 2009;60(12):3534-3545.   [ PubMed ]
  • Vandooren BRM. Mediators of joint remodeling in spondyloarthritis. s.l.: s.n.; 2009. (282pp.) (PhD thesis. Supervisor(s): Tak PP; co-supervisor(s): Baeten DL)   [ UvA Dissertations Online ]
  • Vergunst CE, Gerlag DM, von Moltke L, Karol M, Wyant T, Chi X, Matzkin E, Leach T, Tak PP. MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study. ARTH RHEUM/AR C RES 2009;60(12):3572-3581.   [ PubMed ]
  • Vervoordeldonk MJ, Aalbers CJ, Tak PP. Interferon beta for rheumatoid arthritis: new clothes for an old kid on the block. ANN RHEUM DIS 2009;68(2):157-158.   [ PubMed ]
  • Vosters JL, Landek-Salgado MA, Yin H, Swaim WD, Kimura H, Tak PP, Caturegli P, Chiorini JA. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome. ARTH RHEUM/AR C RES 2009;60(12):3633-3641.   [ PubMed ]
  • Wijbrandts CA. (Anti-)TNF alpha matters in rheumatoid arthritis. s.l.: s.n.; 2009. (221pp.) (ISBN 9789085595861) (PhD thesis. Supervisor(s): Tak PP)   [ UvA Dissertations Online ]
  • Wijbrandts CA, Klaasen R, Dijkgraaf MGW, Gerlag DM, van Eck-Smit BL, Tak PP. Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss. ANN RHEUM DIS 2009;68(3):373-376.   [ PubMed ]
  • Wijbrandts CA, van Leuven SI, Boom HD, Gerlag DM, Stroes EGS, Kastelein JJP, Tak PP. Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis. ANN RHEUM DIS 2009;68(8):1316-1321.   [ PubMed ]

2008

  • Badsha H, Kong KO, Tak PP. Rheumatoid arthritis in the United Arab Emirates. CLIN RHEUMATOL 2008;27(6):739-742.   [ PubMed ]
  • Badsha H, Tak PP. Can Islamic prayers benefit spondyloarthritides? Case report of a patient with ankylosing spondylitis and increased spinal mobility after an intensive regimen of Islamic prayer. RHEUMATOL INT 2008;28(10):1057-1059.   [ PubMed ]
  • Baeten D, Kruithof E, Breban M, Tak PP. Spondylarthritis in the absence of B lymphocytes. ARTH RHEUM/AR C RES 2008;58(3):730-733.   [ PubMed ]
  • Bennink RJ, Thurlings RM, van Hemert FJ, Voermans C, Dohmen SE, van Eck-Smit BL, Tak PP, Busemann-Sokole E. Biodistribution and radiation dosimetry of 99mTc-HMPAO-labeled monocytes in patients with rheumatoid arthritis. J NUCL MED 2008;49(8):1380-1385.   [ PubMed ]
  • Bos WH, Ursum J, de Vries N, Bartelds GM, Wolbink GJ, Nurmohamed MT, van der Horst-Bruinsma IE, van de Stadt RJ, Crusius JBA, Tak PP, Dijkmans BAC, van Schaardenburg D. The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels. ANN RHEUM DIS 2008;67(9):1347-1350.   [ PubMed ]
  • Bruyn GAW, Tate G, Caeiro F, Maldonado-Cocco J, Westhovens R, Tannenbaum H, Bell M, Forre O, Bjorneboe O, Tak PP, Abeywickrama KH, Bernhardt P, van Riel PLC. Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study. ANN RHEUM DIS 2008;67(8):1090-1095.   [ PubMed ]
  • Cantaert T. How is autoimmunity against citrullinated proteins regulated?. s.l.: s.n.; 2008. (259pp.) (ISBN 9789090236094) (PhD thesis. Supervisor(s): Tak PP; co-supervisor(s): Baeten DL)   [ UvA Dissertations Online ]
  • Cantaert T, Kolln J, Timmer T, van der Pouw Kraan TC, Vandooren B, Thurlings RM, Cañete JD, Catrina AI, Out T, Verweij CL, Zhang Y, Tak PP, Baeten D. B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis. J IMMUNOL 2008;181(1):785-794.   [ PubMed ]
  • Cantaert T, Stone MA, ter Borg M, Mogg R, de Vries N, Wilson AG, Tak PP, Baeten D. A functional polymorphism of TIR-domain-containing adaptor protein is not associated with axial spondyloarthritis. ANN RHEUM DIS 2008;67(5):720-722.   [ PubMed ]
  • Dolman KM, Brouwer N, Frakking FNJ, Flatø B, Tak PP, Kuijpers TW, Førre O, Smerdel-Ramoya A. Mannose-binding lectin deficiency is associated with early onset of polyarticular juvenile rheumatoid arthritis: a cohort study. ARTHRITIS RES THER 2008;10(2):R32.   [ PubMed ]
  • Gerlag DM, Tak PP. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials. BEST PRACT RES CL RH 2008;22(2):311-323.   [ PubMed ]
  • Gerlag DM, Tak PP. Rheumatology. S.l.: Elsevier; 2008. (239-247pp.) (4th edition)
  • Gerlag DM, Tak PP. Verlenging van het effect van intra-articulair toegediende corticosteroïden door combinatie hiervan met artroscopische lavage bij patiënten met een inflammatoire artritis van de knie. NED TIJDSCHR GENEESKD 2008;152(36):1953-1955.   [ PubMed ]
  • Grabiec AM, Tak PP, Reedquist KA. Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on?. ARTHRITIS RES THER 2008;10(5):226.   [ PubMed ]
  • Keystone E, Burmester GR, Furie R, Loveless JE, Emery P, Kremer J, Tak PP, Broder MS, Yu E, Cravets M, Magrini F, Jost F. Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. ARTH RHEUM/AR C RES 2008;59(6):785-793.   [ PubMed ]
  • Lebre MC, Jongbloed SL, Tas SW, Smeets TJM, McInnes IB, Tak PP. Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles. AM J PATHOL 2008;172(4):940-950.   [ PubMed ]
  • Lebre MC, Tak PP. Dendritic cell subsets: their roles in rheumatoid arthritis. ACTA REUMATOL PORT 2008;33(1):35-45.   [ PubMed ]
  • Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, Tak PP, Gay RE, Gay S, Kyburz D. Overexpression of Toll-like Receptors 3 and 4 in Synovial Tissue From Patients With Early Rheumatoid Arthritis Toll-like Receptor Expression in Early and Longstanding Arthritis. ARTH RHEUM/AR C RES 2008;58(12):3684-3692.   [ PubMed ]
  • Polzer K, Baeten D, Soleiman A, Distler J, Gerlag DM, Tak PP, Schett G, Zwerina J. Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints. ANN RHEUM DIS 2008;67(11):1610-1616.   [ PubMed ]
  • Raven EEJ, Haverkamp D, Sierevelt IN, van Montfoort DO, Pöll RG, Blankevoort L, Tak PP. Construct Validity and Reliability of the Disability of Arm, Shoulder and Hand Questionnaire for Upper Extremity Complaints in Rheumatoid Arthritis. J RHEUMATOL 2008;35(12):2334-2338.   [ PubMed ]
  • Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, Gianniny L, Korman BD, Padyukov L, Kurreeman FAS, Chang M, Catanese JJ, Ding B, Wong S, van der Helm-van Mil AHM, Neale BM, Coblyn J, Cui J, Tak PP, Wolbink GJ, Crusius JBA, van der Horst-Bruinsma IE, Criswell LA, Amos CI, Seldin MF, Kastner DL, Ardlie KG, Alfredsson L, Costenbader KH, Altshuler D, Huizinga TWJ, Shadick NA, Weinblatt ME, de Vries N, Worthington J, Seielstad M, Toes REM, Karlson EW, Begovich AB, Klareskog L, Gregersen PK, Daly MJ, Plenge RM. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. NAT GENET 2008;40(10):1216-1223.   [ PubMed ]
  • Rihl M, Kellner H, Kellner W, Barthel C, Yu DTY, Tak PP, Zeidler H, Baeten D. Identification of Interleukin-7 as a Candidate Disease Mediator in Spondylarthritis. ARTH RHEUM/AR C RES 2008;58(11):3430-3435.   [ PubMed ]
  • Straub RH, Pongratz G, Cutolo M, Wijbrandts CA, Baeten D, Fleck M, Atzeni F, Grunke M, Kalden JR, Schölmerich J, Lorenz HM, Tak PP, Sarzi-Puttini P. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis. ARTH RHEUM/AR C RES 2008;58(4):976-984.   [ PubMed ]
  • Tak PP, Thurlings RM, Rossier C, Nestorov I, Dimic A, Mircetic V, Rischmueller M, Nasonov E, Shmidt E, Emery P, Munafo A. Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study. ARTH RHEUM/AR C RES 2008;58(1):61-72.   [ PubMed ]
  • Thurlings RM, Gerlag DM, Tak PP. Rituximab bij de behandeling van reumatoïde artritis. NED TIJDSCHR ALLERG 2008;8(4):127-131.
  • Thurlings RM, Vos K, Gerlag DM, Tak PP. Disease Activity-Guided Rituximab Therapy in Rheumatoid Arthritis The Effects of Re-Treatment in Initial Nonresponders Versus Initial Responders. ARTH RHEUM/AR C RES 2008;58(12):3657-3664.   [ PubMed ]
  • Thurlings RM, Vos K, Wijbrandts CA, van Schaardenburg D, Gerlag DM, Tak PP. CD22 is not expressed merely on B cells: comment on the article by Vos et al - Reply. ARTH RHEUM/AR C RES 2008;58(3):912-913.   [ PubMed ]
  • Thurlings RM, Vos K, Wijbrandts CA, Zwinderman AH, Gerlag DM, Tak PP. Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response. ANN RHEUM DIS 2008;67(7):917-925.   [ PubMed ]
  • Thurlings RM, Wijbrandts CA, Mebius RE, Cantaert T, Dinant HJ, van der Pouw-Kraan TCTM, Verweij CL, Baeten D, Tak PP. Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype. ARTH RHEUM/AR C RES 2008;58(6):1582-1589.   [ PubMed ]
  • Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. PHARMACOL THERAPEUT 2008;117(2):244-279.   [ PubMed ]
  • van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Rustenburg F, Baggen JM, Verweij CL, Tak PP. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients. ANN RHEUM DIS 2008;67(4):563-566.   [ PubMed ]
  • van der Pouw Kraan TCTM, van Baarsen LGM, Wijbrandts CA, Voskuyl AE, Rustenburg F, Baggen JM, Dijkmans BAC, Tak PP, Verweij CL. Expression of a pathogen-response program in peripheral blood cells defines a subgroup of rheumatoid arthritis patients. GENES IMMUN 2008;9(1):16-22.   [ PubMed ]
  • van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ESG, Tak PP. Systemic inflammation as a risk factor for atherothrombosis. RHEUMATOLOGY 2008;47(1):3-7.   [ PubMed ]
  • Vandooren B, Cantaert T, Borg MT, Noordenbos T, Kuhlman R, Gerlag D, Bongartz T, Reedquist K, Tak PP, Baeten D. Tumor Necrosis Factor alpha Drives Cadherin 11 Expression in Rheumatoid Inflammation. ARTH RHEUM/AR C RES 2008;58(10):3051-3062.   [ PubMed ]
  • Vandooren B, Cantaert T, Noordenbos T, Tak PP, Baeten D. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. ARTH RHEUM/AR C RES 2008;58(3):718-729.   [ PubMed ]
  • Vergunst CE, Gerlag DM, Lopatinskaya L, Klareskog L, Smith MD, van den Bosch F, Dinant HJ, Lee Y, Wyant T, Jacobson EW, Baeten D, Tak PP. Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial. ARTH RHEUM/AR C RES 2008;58(7):1931-1939.   [ PubMed ]
  • Vervoordeldonk MJBM, Aalbers CJ, Tak PP. Advances in local targeted gene therapy for arthritis: towards clinical reality.. FUTURE RHEUMATOL 2008;3(4):307-309.
  • Wijbrandts CA, Dijkgraaf MGW, Kraan MC, Vinkenoog M, Smeets TJ, Dinant H, Vos K, Lems WF, Wolbink GJ, Sijpkens D, Dijkmans BAC, Tak PP. The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium. ANN RHEUM DIS 2008;67(8):1139-1144.   [ PubMed ]
  • Wijbrandts CA, Remans PH, Klarenbeek PL, Wouters D, van den Bergh Weerman MA, Smeets TJ, Vervoordeldonk MJ, Baeten D, Tak PP. Analysis of Apoptosis in Peripheral Blood and Synovial Tissue Very Early After Initiation of Infliximab Treatment in Rheumatoid Arthritis Patients. ARTH RHEUM/AR C RES 2008;58(11):3330-3339.   [ PubMed ]

2007

  • Adriaansen J. Local gene therapy for the treatment of arthritis. s.l.: s.n.; 2007. (208pp.) (ISBN 9789090213897) (PhD thesis. Supervisor(s): Tak PP; co-supervisor(s): Vervoordeldonk MJBM)   [ UvA Dissertations Online ]
  • Adriaansen J, Fallaux FJ, de Cortie CJ, Vervoordeldonk MJ, Tak PP. Local delivery of beta interferon using an adeno-associated virus type 5 effectively inhibits adjuvant arthritis in rats. J GEN VIROL 2007;88(Part 6):1717-1721.   [ PubMed ]
  • Adriaansen J, Khoury M, de Cortie CJ, Fallaux FJ, Bigey P, Scherman D, Gould DJ, Chernajovsky Y, Apparailly F, Jorgensen C, Vervoordeldonk MJBM, Tak PP. Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent. ANN RHEUM DIS 2007;66(9):1143-1150.   [ PubMed ]
  • Badsha H, Kong KO, Tak PP. Rheumatoid arthritis in Dubai - delayed diagnosis and low usage of disease modifying antirheumatic drugs. ANN RHEUM DIS 2007;66(6):835.   [ PubMed ]
  • Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden L, Dijkmans BAC, Tak PP, Wolbink GJ. Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis. ANN RHEUM DIS 2007;66(7):921-926.   [ PubMed ]
  • Biro E, Nieuwland R, Tak PP, Pronk LM, Schaap MCL, Sturk A, Hack CE. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. ANN RHEUM DIS 2007;66(8):1085-1092.   [ PubMed ]
  • Bresnihan B, Gerlag DM, Rooney T, Smeets TJM, Wijbrandts CA, Boyle D, Fitzgerald O, Kirkham BW, McInnes IB, Smith M, Ulfgren AK, Veale DJ, Tak PP. Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers. J RHEUMATOL 2007;34(3):620-622.   [ PubMed ]
  • Brown DA, Moore J, Johnen H, Smeets TJ, Bauskin AR, Kuffner T, Weedon H, Milliken ST, Tak PP, Smith MD, Breit SN. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. ARTH RHEUM/AR C RES 2007;56(3):753-764.   [ PubMed ]
  • de Rie MA, van Kuijk AWR, Goedkoop AY, Tak PP. Arthritis psoriatica. NED TIJDSCHR GENEESKD 2007;151(31):1716-1722.   [ PubMed ]
  • Gerlag DM, Boyle DL, Rosengren S, Nash T, Tak PP, Firestein GS. Real-time quantitative PCR to detect changes in synovial gene expression in rheumatoid arthritis after corticosteroid treatment. ANN RHEUM DIS 2007;66(4):545-547.   [ PubMed ]
  • Gerlag DM, Tak PP. How useful are synovial biopsies for the diagnosis of rheumatic diseases?. NAT CLIN PRACT RHEUM 2007;3(5):248-249.   [ PubMed ]
  • Jacobs JWG, Creemers MCW, van Agtmael MA, van de Laar MAFJ, van der Poll T, Tak PP, Bijlsma JWJ. TNF-blokkerende geneesmiddelen en infecties; adviezen voor de dagelijkse praktijk. NED TIJDSCHR GENEESKD 2007;151(10):588-593.   [ PubMed ]
  • Kaandorp CJE, van den Broek PJ, Dekhuijzen PNR, Dohle GR, Tak PP, de Vries N. Klinische Probleemstellingen. Onderzoek en diagnostiek van 236 aandoeningen.. S.l.: Prelum Uitgevers; 2007. (528pp.) (ISBN 9789085620426) (Klinische diagnostiek. Deel 1)
  • Khoury M, Adriaansen J, Vervoordeldonk MJBM, Gould D, Chernajovsky Y, Bigey P, Bloquel C, Scherman D, Tak PP, Jorgensen C, Apparailly F. Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis. J GENE MED 2007;9(7):596-604.   [ PubMed ]
  • Lassere MN, Johnson KR, Boers M, Tugwell P, Brooks P, Simon L, Strand V, Conaghan PG, Ostergaard M, Maksymowych WP, Landewe R, Bresnihan B, Tak PP, Wakefield R, Mease P, Bingham CO III, Hughes M, Altman D, Buyse M, Galbraith S, Wells G. Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema. J RHEUMATOL 2007;34(3):607-615.   [ PubMed ]
  • Lavini C, de Jonge MC, van de Sande MGH, Tak PP, Nederveen AJ, Maas M. Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system. MAGN RESON IMAGING 2007;25(5):604-612.   [ PubMed ]
  • Ludikhuize J, de Launay D, Groot D, Smeets TJM, Vinkenoog M, Sanders ME, Tas SW, Tak PP, Reedquist KA. Inhibition of forkhead box class O family member transcription factors in rheumatoid synovial tissue. ARTH RHEUM/AR C RES 2007;56(7):2180-2191.   [ PubMed ]
  • Rooney T, Bresnihan B, Andersson U, Gogarty M, Kraan M, Schumacher HR, Ulfgren AK, Veale DJ, Youssef PP, Tak PP. Microscopic measurement of inflammation in synovial tissue: inter-observer agreement for manual quantitative, semiquantitative and computerised digital image analysis. ANN RHEUM DIS 2007;66(12):1656-1660.   [ PubMed ]
  • Tas SW, Vervoordeldonk MJ, Hajji N, Schuitemaker JHN, van der Sluijs KF, May MJ, Ghosh S, Kapsenberg ML, Tak PP, de Jong EC. Noncanonical NF-kappa B signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. BLOOD 2007;110(5):1540-1549.   [ PubMed ]
  • Timmer TCG, Baltus B, Vondenhoff M, Huizinga TWJ, Tak PP, Verweij CL, Mebius RE, van der Pouw Kraan TCTM. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology - Identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. ARTH RHEUM/AR C RES 2007;56(8):2492-2502.   [ PubMed ]
  • van der Hall PO, Kraan MC, Tak PP. Quantitative image analysis of synovial tissue. METHODS MOL MED 2007;135:121-143.   [ PubMed ]
  • van der Kamp R, Tak PP, Jansen HM, Bresser P. Interstitial lung disease as the first manifestation of systemic sclerosis. NETH J MED 2007;65(10):390-394.   [ PubMed ]
  • van der Pouw Kraan TCTM, Wijbrandts CA, van Baarsen LGM, Voskuyl AE, Rustenburg F, Baggen JM, Ibrahim SM, Fero M, Dijkmans BAC, Tak PP, Verweij CL. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. ANN RHEUM DIS 2007;66(8):1008-1014.   [ PubMed ]
  • van Hemert FJ, Thurlings R, Dohmen SE, Voermans C, Tak PP, van Eck-Smit BLF, Bennink RJ. Labeling of autologous monocytes with 99mTc-HMPAO at very high specific radioactivity. NUCL MED BIOL 2007;34(8):933-938.   [ PubMed ]
  • van Roon JAG, Hartgring SAY, Wenting-van Wijk M, Jacobs KMG, Tak PP, Bijlsma JWJ, Lafeber FPJG. Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis. ANN RHEUM DIS 2007;66(5):664-669.   [ PubMed ]
  • Vergunst CE, Gerlag DM, Dinant H, Schulz L, Vinkenoog M, Smeets TJM, Sanders ME, Reedquist KA, Tak PP. Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation. RHEUMATOLOGY 2007;46(12):1773-1778.   [ PubMed ]
  • Vervoordeldonk MJBM, Adriaansen J, Fallaux FJ, Tak PP. Gene therapy for rheumatoid arthritis.. ANTI-INFLAMM AND ANTI-ALLERG AGENTS MED CHEM 2007;6:109-120.
  • Vierboom MPM, Jonker M, Tak PP, 't Hart BA. Preclinical models of arthritic disease in non-human primates. DRUG DISCOV TODAY 2007;12(7-8):327-335.   [ PubMed ]
  • Vos K, Thurlings RM, Wijbrandts CA, van Schaardenburg D, Gerlag DM, Tak PP. Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis. ARTH RHEUM/AR C RES 2007;56(3):772-778.   [ PubMed ]
  • Weisscher N, Wijbrandts CA, de Haan R, Glas CAW, Vermeulen M, Tak PP. The Academic Medical Center Linear Disability Score item bank: psychometric properties of a new generic disability measure in rheumatoid arthritis. J RHEUMATOL 2007;34(6):1222-1228.   [ PubMed ]
  • Wijbrandts CA, Vergunst CE, Haringman JJ, Gerlag DM, Smeets TJM, Tak PP. Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker. ARTH RHEUM/AR C RES 2007;56(11):3869-3871.   [ PubMed ]

2006

  • Adriaansen J, Kuhlman RR, van Holten J, Kaynor C, Vervoordeldonk MJBM, Tak PP. Intraarticular interferon-beta gene therapy ameliorates adjuvant arthritis in rats. HUM GENE THER 2006;17(10):985-996.   [ PubMed ]
  • Adriaansen J, Vervoordeldonk MJ, Vanderbyl S, de Jong G, Tak PP. A novel approach for gene therapy: engraftment of fibroblasts containing the artificial chromosome expression system at the site of inflammation. J GENE MED 2006;8(1):63-71.   [ PubMed ]
  • Adriaansen J, Vervoordeldonk MJBM, Tak PP. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes. RHEUMATOLOGY 2006;45(6):656-668.   [ PubMed ]
  • Bonarius HPJ, Baas F, Remmerswaal EBM, van Lier RAW, ten Berge IJM, Tak PP, de Vries N. Monitoring the T-cell receptor repertoire at single-clone resolution. PLOS ONE 2006;1:e55.   [ PubMed ]
  • Cantaert T, de Rycke L, Bongartz T, Matteson EL, Tak PP, Nicholas AP, Baeten D. Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient!. ARTH RHEUM/AR C RES 2006;54(11):3381-3389.   [ PubMed ]
  • Cha HS, Boyle DL, Inoue T, Schoot R, Tak PP, Pine P, Firestein GS. A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes. J PHARMACOL EXP THER 2006;317(2):571-578.   [ PubMed ]
  • de Rycke L, Kruithof E, Vandooren B, Tak PP, Baeten D. Pathogenesis of spondyloarthritis: insights from synovial membrane studies. CURR RHEUMATOL REP 2006;8(4):275-282.   [ PubMed ]
  • Haringman JJ, Gerlag DM, Smeets TJM, Baeten D, van den Bosch F, Bresnihan B, Breedveld FC, Dinant HJ, Legay F, Gram H, Loetscher P, Schmouder R, Woodworth T, Tak PP. A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. ARTH RHEUM/AR C RES 2006;54(8):2387-2392.   [ PubMed ]
  • Haringman JJ, Smeets TJM, Reinders-Blankert P, Tak PP. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. ANN RHEUM DIS 2006;65(3):294-300.   [ PubMed ]
  • Jahangier ZN, Jacobs JWG, Kraan MC, Wenting MJG, Smeets TJ, Bijlsma JWJ, Lafeber FPJG, Tak PP. Pretreatment macrophage infiltration of the synovium predicts the clinical effect of both radiation synovectomy and intra-articular glucocorticoids. ANN RHEUM DIS 2006;65(10):1286-1292.   [ PubMed ]
  • Jongbloed SL, Lebre MC, Fraser AR, Gracie JA, Sturrock RD, Tak PP, McInnes IB. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. ARTHRITIS RES THER 2006;8(1):R15.   [ PubMed ]
  • Kop EN, Adriaansen J, Smeets TJM, Vervoordeldonk MJ, van Lier RAW, Hamann J, Tak PP. CD97 neutralisation increases resistance to collagen-induced arthritis in mice. ARTHRITIS RES THER 2006;8(5):R155.   [ PubMed ]
  • Kruithof E, de Rycke L, Vandooren B, de Keyser F, Fitzgerald O, McInnes I, Tak PP, Bresnihan B, Veys EM, Baeten D. Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis. ARTH RHEUM/AR C RES 2006;54(6):1795-1804.   [ PubMed ]
  • Kruithof E, van den Bossche V, de Rycke L, Vandooren B, Joos R, Cañete JD, Tak PP, Boots AMH, Veys EM, Baeten D. Distinct synovial immunopathologic characteristics of juvenile-onset spondylarthritis and other forms of juvenile idiopathic arthritis. ARTH RHEUM/AR C RES 2006;54(8):2594-2604.   [ PubMed ]
  • Lodde BM, Baum BJ, Tak PP, Illei G. Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment. ANN RHEUM DIS 2006;65(11):1406-1413.   [ PubMed ]
  • Lodde BM, Mineshiba F, Kok MR, Wang J, Zheng C, Schmidt M, Cotrim AP, Kriete M, Tak PP, Baum BJ. NOD mouse model for Sjögren's syndrome: lack of longitudinal stability. ORAL DIS 2006;12(6):566-572.   [ PubMed ]
  • Lodde BM, Mineshiba F, Wang J, Cotrim AP, Afione S, Tak PP, Baum BJ. Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome. ANN RHEUM DIS 2006;65(2):195-200.   [ PubMed ]
  • Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR. Re: Traditional cardiovascular risk factors in primary Sjogren's syndrome: role of dyslipidaemia. RHEUMATOLOGY 2006;45(12):1581-1582.
  • Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR. Serum lipid levels in Sjögren's syndrome. RHEUMATOLOGY 2006;45(4):481-484.   [ PubMed ]
  • Reedquist KA, Ludikhuize J, Tak PP. Phosphoinositide 3-kinase signalling and FoxO transcription factors in rheumatoid arthritis. BIOCHEM SOC T 2006;34(Part 5):727-730.   [ PubMed ]
  • Remans PH, Gerlag DM, Wijbrandts CA, Jansen G, Anas AA, Reedquist KA, Tak PP. In vitro evidence that treatment with high dose methylprednisolone pulse therapy is superior to high dose prednisolone or dexamethasone. ARTH RHEUM/AR C RES 2006;54(9 Suppl. S):S240-S241.
  • Remans PHJ, Wijbrandts CA, Sanders ME, Toes RE, Breedveld FC, Tak PP, van Laar JM, Reedquist KA. CTLA-4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells. ARTH RHEUM/AR C RES 2006;54(10):3135-3143.   [ PubMed ]
  • Smith MD, Baeten D, Ulfgren AK, McInnes IB, FitzGerald O, Bresnihan B, Tak PP, Veale D. Standardisation of synovial tissue infiltrate analysis: how far have we come? how much further do we need to go?. ANN RHEUM DIS 2006;65(1):93-100.   [ PubMed ]
  • Tak PP. Chemokine inhibition in inflammatory arthritis. BEST PRACT RES CL RH 2006;20(5):929-939.   [ PubMed ]
  • Tak PP, Bacchi M, Bertolino M. Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis. EUR J DRUG METAB PH 2006;31(2):109-116.   [ PubMed ]
  • Tas SW, Adriaansen J, Hajji N, Bakker AC, Firestein GS, Vervoordeldonk MJ, Tak PP. Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5. HUM GENE THER 2006;17(8):821-832.   [ PubMed ]
  • Tas SW, Hajji N, Stenvers DJ, Firestein GS, Vervoordeldonk MJ, Tak PP. Reduction of proinflammatory cytokine expression in the synovium by targeting IKKbeta in vivo in a rat model. ARTH RHEUM/AR C RES 2006;54(11):3716-3718.   [ PubMed ]
  • Tas SW, Vervoordeldonk MJ, Hajji N, May MJ, Ghosh S, Tak PP. Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation. ARTHRITIS RES THER 2006;8(4):R86.   [ PubMed ]
  • Thurlings RM, Vos K, Gerlag DM, Tak PP. De humorale respons bij reumatoïde artritis en het effect van B-celdepleterende therapie. NED TIJDSCHR GENEESKD 2006;150(30):1657-1661.   [ PubMed ]
  • van Holten J. Interferon beta for the treatment of rheumatoid arthritis?. S.l.: s.n.; 2006. (144pp.) (PhD thesis. Supervisor(s): Tak PP)   [ UvA Dissertations Online ]
  • van Kuijk AWR, Reinders-Blankert P, Smeets TJM, Dijkmans BAC, Tak PP. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. ANN RHEUM DIS 2006;65(12):1551-1557.   [ PubMed ]
  • Wolbink GJ, Vis M, Lems W, Voskuyl AE, de Groot E, Nurmohamed MT, Stapel S, Tak PP, Aarden L, Dijkmans B. Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis. ARTH RHEUM/AR C RES 2006;54(3):711-715.   [ PubMed ]

2005

  • Adriaansen J, Tas SW, Klarenbeek PL, Bakker AC, Apparailly F, Firestein GS, Jorgensen C, Vervoordeldonk MJBM, Tak PP. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy. ANN RHEUM DIS 2005;64(12):1677-1684.   [ PubMed ]
  • Apparailly F, Khoury M, Vervoordeldonk MJB, Adriaansen J, Gicquel E, Perez N, Riviere C, Louis-Plence P, Noel D, Danos O, Douar AM, Tak PP, Jorgensen C. Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints. HUM GENE THER 2005;16(4):426-434.   [ PubMed ]
  • Berckmans RJ, Nieuwland R, Kraan MC, Schaap MCL, Pots D, Smeets TJM, Sturk A, Tak PP. Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. ARTHRITIS RES THER 2005;7(3):R536-R544.   [ PubMed ]
  • Bresnihan B, Baeten D, Firestein GS, Fitzgerald OM, Gerlag DM, Haringman JJ, McInnes IB, Reece RJ, Smith MD, Ulfgren AK, Veale DJ, Tak PP. Synovial tissue analysis in clinical trials. J RHEUMATOL 2005;32(12):2481-2484.   [ PubMed ]
  • de Vries N, Shen N, Tak PP, Shunie CH. Frontiers in rheumatology research: report from the 1st Chinese-Dutch rheumatology workshop. http://www.rheuma21st.com. - 2005;- [aheadofprint]
  • de Vries N, Tak PP. The response to anti-TNF-alpha treatment: gene regulation at the bedside. RHEUMATOLOGY 2005;44(6):705-707.   [ PubMed ]
  • de Vries N, Zwinderman AH, Tak PP. The interaction of smoking and the HLA-DRB1 shared epitope in rheumatoid factor-positive rheumatoid arthritis: comment on the article by Padyukov et al. ARTH RHEUM/AR C RES 2005;52(11):3676-3676; author reply 3678.   [ PubMed ]
  • Gerlag D, Tak PP. Synovial biopsy. BEST PRACT RES CL RH 2005;19(3):387-400.   [ PubMed ]
  • Goedkoop AY. Effects of biological response modifiers in psoriasis and psoriatic arthritis. S.l.: s.n.; 2005. (172 + ill.pp.) (ISBN 90-9019312-X) (PhD thesis. Supervisor(s): Bos JD, Tak PP; co-supervisor(s): de Rie MA, Teunissen MBM)   [ UvA Dissertations Online ]
  • Goedkoop AY, de Rie MA, Teunissen MBM, Picavet DI, van der Hall PO, Bos JD, Tak PP, Kraan MC. Digital image analysis for the evaluation of the inflammatory infiltrate in psoriasis. ARCH DERMATOL RES 2005;297(2):51-59.   [ PubMed ]
  • Goldbach-Mansky R, Suson S, Wesley R, Hack CE, El-Gabalawy HS, Tak PP. Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis. ANN RHEUM DIS 2005;64(5):715-721.   [ PubMed ]
  • Haringman JJ. Fatal attraction: chemokines and rheumatoid arthritis. S.l.: s.n.; 2005. (132pp.) (ISBN 90-9019600-5) (PhD thesis. Supervisor(s): Tak PP)   [ UvA Dissertations Online ]
  • Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJM, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. ANN RHEUM DIS 2005;64(6):834-838.   [ PubMed ]
  • Haringman JJ, Oostendorp RL, Tak PP. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis. EXPERT OPIN EMERG DR 2005;10(2):299-310.   [ PubMed ]
  • Haringman JJ, Vinkenoog M, Gerlag DM, Smeets TJM, Zwinderman AH, Tak PP. Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis. ARTHRITIS RES THER 2005;7(4):R862-R867.   [ PubMed ]
  • Kasperkovitz PV, Timmer TCG, Smeets TJ, Verbeet NL, Tak PP, van Baarsen LGM, Baltus B, Huizinga TWJ, Pieterman E, Fero M, Firestein GS, van der Pouw Kraan TCTM, Verweij CL. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity - Evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. ARTH RHEUM/AR C RES 2005;52(2):430-441.   [ PubMed ]
  • Kok MR. Use of localized gene transfer to develop novel treatment strategies for the salivary component of Sjögren's syndrome. S.l.: s.n.; 2005. (161pp.) (ISBN 90-809712-1-9) (PhD thesis. Supervisor(s): Tak PP; co-supervisor(s): Baum BJ)   [ UvA Dissertations Online ]
  • Kok MR, Voutetakis A, Yamano S, Wang J, Cotrim A, Katano H, Bossis I, Chiorini JA, Tran SD, Tak PP, Baum BJ. Immune responses following salivary gland administration of recombinant adeno-associated virus serotype 2 vectors. J GENE MED 2005;7(4):432-441.   [ PubMed ]
  • Kop EN, Kwakkenbos MJ, Teske GJD, Kraan MC, Smeets TJ, Stacey M, Lin HH, Tak PP, Hamann J. Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue. ARTH RHEUM/AR C RES 2005;52(2):442-450.   [ PubMed ]
  • Kroot EJA, Kraan MC, Smeets TJM, Maas M, Tak PP, Wouters JMGW. Tumour necrosis factor alpha blockade in treatment resistant pigmented villonodular synovitis. ANN RHEUM DIS 2005;64(3):497-499.   [ PubMed ]
  • Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR. Adult heart block is associated with disease activity in primary Sjogren's syndrome. SCAND J RHEUMATOL 2005;34(5):383-386.   [ PubMed ]
  • Mease PJ, Behrens F, Boehncke WH, Feldman SR, FitzGerald O, Gladmann DD, Helliwell PS, Nash P, Olivieri I, Taylor WJ, Tak PP. Discussion: Assessment of psoriatic arthritis. ANN RHEUM DIS 2005;64(SupplII):ii69-ii73.
  • Remans PHJ, van Oosterhout M, Smeets TJM, Sanders M, Frederiks WM, Reedquist KA, Tak PP, Breedveld FC, van Laar JM. Intracellular free radical production in synovial T lymphocytes from patients with rheumatoid arthritis. ARTH RHEUM/AR C RES 2005;52(7):2003-2009.   [ PubMed ]
  • Rowshani AT, Remans P, Rozemuller A, Tak PP. Cerebral vasculitis as a primary manifestation of systemic lupus erythematosus. ANN RHEUM DIS 2005;64(5):784-786.   [ PubMed ]
  • Tak PP. Analyzing synovial tissue samples. What can we learn about early rheumatoid arthritis, the heterogeneity of the disease, and the effects of treatment?. J RHEUMATOL 2005;32(Suppl. 72):25-26.   [ PubMed ]
  • Tak PP. Effects of infliximab treatment on rheumatoid synovial tissue. J RHEUMATOL 2005;32(Suppl. 74):31-34.   [ PubMed ]
  • Tas SW, de Jong EC, Hajji N, May MJ, Ghosh S, Vervoordeldonk MJ, Tak PP. Selective inhibition of NF-kappaB in dendritic cells by the NEMO-binding domain peptide blocks maturation and prevents T cell proliferation and polarization. EUR J IMMUNOL 2005;35(4):1164-1174.   [ PubMed ]
  • Tas SW, Remans PHJ, Reedquist KA, Tak PP. Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: Towards innovative antirheumatic therapy. CURR PHARM DESIGN 2005;11(5):581-611.   [ PubMed ]
  • van Holten J, Pavelka K, Vencovsky J, Stahl H, Rozman B, Genovese M, Kivitz AJ, Alvaro J, Nuki G, Furst DE, Herrero-Beaumont G, McInnes IB, Musikic P, Tak PP. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. ANN RHEUM DIS 2005;64(1):64-69.   [ PubMed ]
  • van Holten J, Smeets TJM, Blankert P, Tak PP. Expression of interferon beta in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis. ANN RHEUM DIS 2005;64(12):1780-1782.   [ PubMed ]
  • van Mello NM, Pillemer SR, Tak PP, Sankar V. B cell MALT lymphoma diagnosed by labial minor salivary gland biopsy in patients screened for Sjogren's syndrome. ANN RHEUM DIS 2005;64(3):471-473.   [ PubMed ]
  • Varekamp I, Haafkens JA, Detaille SI, Tak PP, van Dijk FJH. Preventing work disability among employees with rheumatoid arthritis: what medical professionals can learn from the patients' perspective. ARTH RHEUM/AR C RES 2005;53(6):965-972.   [ PubMed ]
  • Vergunst CE, Tak PP. Chemokines: their role in rheumatoid arthritis. CURR RHEUMATOL REP 2005;7(5):382-388.   [ PubMed ]
  • Vergunst CE, Tak PP. Pseudo-jicht bij 3 patiënten met vermeende, therapieresistente reumatoide artritis. NED TIJDSCHR GENEESKD 2005;149(14):773-777.   [ PubMed ]
  • Vergunst CE, van de Sande MGH, Lebre MC, Tak PP. The role of chemokines in rheumatoid arthritis and osteoarthritis. SCAND J RHEUMATOL 2005;34(6):415-425.   [ PubMed ]
  • Wolbink GJ, Voskuyl AE, Lems WF, de Groot E, Nurmohamed MT, Tak PP, Dijkmans BAC, Aarden L. Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis. ANN RHEUM DIS 2005;64(5):704-707.   [ PubMed ]

2004

  • Bijlsma JWJ, Geusens PPMM, Kallenberg CGM, Tak PP, editors. Reumatologie en klinische immunologie. Houten: Bohn Stafleu Van Loghum; 2004. (-pp.) (ISBN 90 313 4000 6)
  • Bresnihan B, Tak PP. Synovial pathology. In: Oxford textbook of rheumatology; 3th ed. Oxford: Oxford University Press; 2004. p. 360-366.
  • de Groot JR, TeKoppele JM, Harris ED, Tak PP. Biological markers. In: Harris ED, Budd RC, Firestein GC, Genovese MC, Sergent JS, Ruddy S, Sledge CB, editors. Kelley's textbook of rheumatology, vol. I 7th ed. Philadelphia: Elsevier Saunders; 2004. p. 728-738.
  • de Keyser F, Tak PP. Ongedifferentieerde artritis. In: Bijlsma JWJ, Geusens PPMM, Kallenberg CGM, Tak PP, editors. Reumatologie en klinische immunologie. Houten: Bohn Stafleu Van Loghum; 2004. p. 102-110.
  • Gerlag D, Tak PP. Synovial fluid analysis, synovial biopsy, and synovial pathology. In: Harris ED, Budd RC, Firestein GC, Genovese MC, Sergent JS, Ruddy S, Sledge CB, editors. Kelley's textbook of rheumatology, vol. I 7th ed. Philadelphia: Elsevier Saunders; 2004. p. 675-691.
  • Gerlag DM, Haringman JJ, Smeets TJM, Zwinderman AH, Kraan MC, Laud PJ, Morgan S, Nash AFP, Tak PP. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. ARTH RHEUM/AR C RES 2004;50(12):3783-3791.   [ PubMed ]
  • Goedkoop AY, de Rie MA, Picavet DI, Kraan MC, Dinant HJ, van Kuijk AWR, Tak PP, Bos JD, Teunissen MBM. Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermis. ARCH DERMATOL RES 2004;295(11):465-473.   [ PubMed ]
  • Goedkoop AY, Kraan MC, Picavet DI, de Rie MA, Teunissen MBM, Bos JD, Tak PP. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. ARTHRITIS RES THER 2004;6(4):R326-R334.   [ PubMed ]
  • Goedkoop AY, Kraan MC, Tak PP, Bos JD, de Rie MA, Picavet HSJ, Teunissen MBM. In vitro studies met biologicals in psoriasis. NED TIJDSCHR DERMATOL VENEREOL 2004;14(juni):202-204.
  • Goedkoop AY, Kraan MC, Teunissen MBM, Picavet DI, de Rie MA, Bos JD, Tak PP. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis. ANN RHEUM DIS 2004;63(7):769-773.   [ PubMed ]
  • Haringman JJ, Ludikhuize J, Tak PP. Chemokines in joint disease: the key to inflammation?. ANN RHEUM DIS 2004;63(10):1186-1194.   [ PubMed ]
  • Haringman JJ, Tak PP. Blokkade van chemokinen bij chronische ontstekingsziekten. NED TIJDSCHR GENEESKD 2004;148(36):1760-1764.   [ PubMed ]
  • Haringman JJ, Tak PP. Chemokine blockade: a new era in the treatment of rheumatoid arthritis?. ARTHRITIS RES THER 2004;6(3):93-97.   [ PubMed ]
  • Kasperkovitz PV, Verbeet NL, Smeets TJ, van Rietschoten JGI, Kraan MC, van der Pouw Kraan TCTM, Tak PP, Verweij CL. Activation of the STAT1 pathway in rheumatoid arthritis. ANN RHEUM DIS 2004;63(3):233-239.   [ PubMed ]
  • Kraan MC, Haringman JJ, Weedon H, Barg EC, Smith MD, Ahern MJ, Smeets TJM, Breedveld FC, Tak PP. T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis. ANN RHEUM DIS 2004;63(5):483-488.   [ PubMed ]
  • Kraan MC, Smeets TJM, van Loon MJ, Breedveld FC, Dijkmans BAC, Tak PP. Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis. ANN RHEUM DIS 2004;63(9):1056-1061.   [ PubMed ]
  • Lodde BM, Delporte C, Goldsmith CM, Tak PP, Baum BJ. A recombinant adenoviral vector encoding functional vasoactive intestinal peptide. BIOCHEM BIOPH RES CO 2004;319(1):189-192.   [ PubMed ]
  • Remans PHJ, Gringhuis SI, van Laar JM, Sanders ME, Papendrecht-van der Voort EAM, Zwartkruis FJT, Levarht EWN, Rosas M, Coffer PJ, Breedveld FC, Bos JL, Tak PP, Verweij CL, Reedquist KA. Rap1 signaling is required for suppression of Ras-generated reactive oxygen species and protection against oxidative stress in T lymphocytes. J IMMUNOL 2004;173(2):920-931.   [ PubMed ]
  • Tak PP. IFN-beta in rheumatoid arthritis. FRONT BIOSCI 2004;9(Suppl. S):3242-3247.   [ PubMed ]
  • van Holten J, Reedquist K, Sattonet-Roche P, Smeets TJM, Plater-Zyberk C, Vervoordeldonk MJ, Tak PP. Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. ARTHRITIS RES THER 2004;6(3):R239-R249.   [ PubMed ]
  • van Riel PLCM, Tak PP. Reumatoïde artritis. In: Bijlsma JWJ, Geusens PPMM, Kallenberg CGM, Tak PP, editors. Reumatologie en klinische immunologie. Houten: Bohn Stafleu Van Loghum; 2004. p. 66-81.
  • Vos K, de Bois MHW, Pauwels EKJ, Tak PP. Arthritis: current status of scintigraphy and future trends. In: Nuclear medicine in clinical diagnosis and treatment. S.l.: s.n.; 2004. p. ch.94-.
  • Vossenaar ER, Smeets TJM, Kraan MC, Raats JM, van Venrooij WJ, Tak PP. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. ARTH RHEUM/AR C RES 2004;50(11):3485-3494.   [ PubMed ]

2003

  • de Vries N, Tak PP. Possible role of shared epitope status in the relationship between matrix metalloproteinase 3 genotype and radiographic progression of rheumatoid arthritis: comment on the article by Constantin et al. ARTH RHEUM/AR C RES 2003;48(4):1162-1163.   [ PubMed ]
  • de Vries N, Tak PP, Tijssen H, van Riel PLCM, van de Putte LBA. Female sex increases risk for rheumatoid arthritis only in individuals encoding low-risk HLA-DRB1 alleles. ARTH RHEUM/AR C RES 2003;48(6):1762-1763.   [ PubMed ]
  • Emery P, Reece RJ, Kraan MC, O'Connor PJ, Radjenovic A, Veale DJ, Ridgway JP, Gibbon WW, Breedveld FC, Tak PP. Unproven hypothesis that leflunomide is better than methotrexate as measured by magnetic resonance imaging: comment on the article by Reece et al - Reply (letter). ARTH RHEUM/AR C RES 2003;48(1):271.
  • Haringman JJ, Kraan MC, Smeets TJM, Zwinderman KH, Tak PP. Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis. ANN RHEUM DIS 2003;62(8):715-721.   [ PubMed ]
  • Haynes DR, Barg E, Crotti TN, Holding C, Weedon H, Atkins GJ, Zannetino A, Ahern MJ, Coleman M, Roberts-Thomson PJ, Kraan M, Tak PP, Smith MD. Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. RHEUMATOLOGY 2003;42(1):123-134.   [ PubMed ]
  • Kok MR, Baum BJ, Tak PP, Pillemer SR. Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjogren's syndrome. ANN RHEUM DIS 2003;62(11):1038-1046.   [ PubMed ]
  • Kok MR, Yamano S, Lodde BM, Wang J, Couwenhoven RI, Yakar S, Voutetakis A, Leroith D, Schmidt M, Afione S, Pillemer SR, Tsutsui MT, Tak PP, Chiorini JA, Baum BJ. Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjogren's syndrome. HUM GENE THER 2003;14(17):1605-1618.   [ PubMed ]
  • Kraan MC, Reece RJ, Smeets TJM, Veale DJ, Emery P, Tak PP. Does concomitant osteoarthritis affect histopathologic changes in patients with rheumatoid arthritis? Reply. ARTH RHEUM/AR C RES 2003;48(4):1162.
  • Smeets TJM. Immunohistochemical analysis of rheumatoid synovial tissue: methodologic and pathogenetic studies. S.l.: s.n.; 2003. (119pp.) (ISBN 90-5170683-9) (PhD thesis. Supervisor(s): Tak PP, Breedveld FC)   [ UvA Dissertations Online ]
  • Smeets TJM, Barg EC, Kraan MC, Smith MD, Breedveld FC, Tak PP. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. ANN RHEUM DIS 2003;62(7):635-638.   [ PubMed ]
  • Smeets TJM, Kraan MC, van Loon ME, Tak PP. Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue. ARTH RHEUM/AR C RES 2003;48(8):2155-2162.   [ PubMed ]
  • Smith MD, Barg E, Weedon H, Papengelis V, Smeets T, Tak PP, Kraan M, Coleman M, Ahern MJ. Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. ANN RHEUM DIS 2003;62(4):303-307.   [ PubMed ]
  • t'Hart BA, Vervoordeldonk M, Heeney JL, Tak PP. Gene therapy in nonhuman primate models of human autoimmune disease. GENE THER 2003;10(10):890-901.   [ PubMed ]
  • Tak PP, Bresnihan B. European synovitis study group. ANN RHEUM DIS 2003;62(12):1252.
  • van der Pouw Kraan TCTM, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJM, Kraan MC, Fero M, Tak PP, Huizinga TWJ, Pieterman E, Breedveld FC, Alizadeh AA, Verweij CL. Rheumatoid arthritis is a heterogeneous disease - Evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. ARTH RHEUM/AR C RES 2003;48(8):2132-2145.   [ PubMed ]

2002

  • Berckmans RJ, Nieuwland R, Tak PP, Böing AN, Romijn FPHTM, Kraan MC, Breedveld FC, Hack CE, Sturk A. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. ARTH RHEUM/AR C RES 2002;46(11):2857-2866.   [ PubMed ]
  • Breedveld FC, Bijlsma JWJ, van de Laar MAFJ, Landewe RBM, van Riel PLCM, van Rijswijk MH, Tak PP, de Vries N. Voorlopige behandelrichtlijn Anakinra. Stand van zaken: bericht van het bestuur. NED TIJDSCHR REUMATOL 2002;4:69-71.
  • Brinkman DMC, ten Cate R, Vossen JM, Smeets TJM, Kraan MC, Tak PP. Decrease in synovial cellularity and cytokine expression after autologous stem cell transplantation in patients with juvenile idiopathic arthritis. ARTH RHEUM/AR C RES 2002;46(4):1121-1123.   [ PubMed ]
  • Crotti TN, Smith MD, Weedon H, Ahern MJ, Findlay DM, Kraan M, Tak PP, Haynes DR. Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. ANN RHEUM DIS 2002;61(12):1047-1054.   [ PubMed ]
  • Kraan MC, Reece RJ, Smeets TJM, Veale DJ, Emery P, Tak PP. Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients - Implications for pathogenesis and evaluation of treatment. ARTH RHEUM/AR C RES 2002;46(8):2034-2038.   [ PubMed ]
  • Kraan MC, van Kuijk AWR, Dinant HJ, Goedkoop AY, Smeets TJM, de Rie MA, Dijkmans BAC, Vaishnaw AK, Bos JD, Tak PP. Alefacept treatment in psoriatic arthritis - Reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis. ARTH RHEUM/AR C RES 2002;46(10):2776-2784.   [ PubMed ]
  • Reece RJ, Kraan MC, Radjenovic A, Veale DJ, O'Connor PJ, Ridgway JP, Gibbon WW, Breedveld FC, Tak PP, Emery P. Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. ARTH RHEUM/AR C RES 2002;46(2):366-372.   [ PubMed ]
  • Smeets TJM, Vossenaar ER, van Venrooij WJ, Tak PP. Is expression of intracellular citrullinated proteins in synovial tissue specific for rheumatoid arthritis? Comment on the article by Baeten et al. ARTH RHEUM/AR C RES 2002;46(10):2824-2826.   [ PubMed ]
  • Smith MD, Tak PP. Rheumatoid arthritis: new insights into the role of synovial inflammation in joint destruction. MOD RHEUMATOL 2002;12:287-293.
  • van Holten J, Plater-Zyberk C, Tak PP. Interferon-beta for treatment of rheumatoid arthritis?. ARTHRITIS RES 2002;4(6):346-352.   [ PubMed ]
  • Vervoordeldonk MJBM, Tak PP. Cytokines in rheumatoid arthritis. CURR RHEUMATOL REP 2002;4(3):208-217.   [ PubMed ]

2001

  • Vervoordeldonk MJBM, Tak PP. Gene therapy in rheumatic diseases. BEST PRACT RES CL RH 2001;15(5):771-788.

1999

  • Hamann J, Wishaupt JO, van Lier RA, Smeets TJ, Breedveld FC, Tak PP. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. ARTH RHEUM/AR C RES 1999;42(4):650-658.   [ PubMed ]
  • Maurice MM, Nakamura H, Gringhuis S, Okamoto T, Yoshida S, Kullmann F, Lechner S, van der Voort EA, Leow A, Versendaal J, Muller-Ladner U, Yodoi J, Tak PP, Breedveld FC, Verweij CL. Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. ARTH RHEUM/AR C RES 1999;42(11):2430-2439.   [ PubMed ]

1997

  • Maurice MM, Lankester AC, Bezemer AC, Geertsma MF, Tak PP, Breedveld FC, van Lier RA, Verweij CL. Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J IMMUNOL 1997;159(6):2973-2978.   [ PubMed ]

1996

  • Tak PP, Hintzen RQ, Teunissen JJ, Smeets TJ, Daha MR, van Lier RA, Kluin PM, Meinders AE, Swaak AJ, Breedveld FC. Expression of the activation antigen CD27 in rheumatoid arthritis. CLIN IMMUNOL IMMUNOPATHOL 1996;80(2):129-138.   [ PubMed ]

Search th alphabetical index

Wijzigingen doorgeven? Stuur een mail naar de bibliotheek

 
  • Home
  • Adres en Route
  • Contact
  • Vacatures
  • Uw browser ondersteunt geen Flash of Flash-ondersteuning is uitgeschakeld,
    om te installeren klik dan hier.